Jihong Chen Selected Research

HLA-DRB1 Chains (HLA DRB1)

1/2021

MicroRNA Variants and HLA-miRNA Interactions are Novel Rheumatoid Arthritis Susceptibility Factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jihong Chen Research Topics

Disease

9	Amyloidosis 10/2023 - 09/2017
8	Polyneuropathies (Polyneuropathy) 01/2021 - 09/2017
5	Neoplasms (Cancer) 01/2023 - 12/2006
3	Body Weight (Weight, Body) 10/2023 - 01/2018
3	COVID-19 04/2023 - 09/2022
3	Chronic Renal Insufficiency 01/2022 - 01/2020
2	Nasopharyngeal Carcinoma 01/2024 - 08/2020
2	Rheumatoid Arthritis 10/2023 - 01/2021
2	Thrombosis (Thrombus) 01/2023 - 01/2022
2	Hyperlipidemias (Hyperlipidemia) 06/2022 - 04/2022
2	Diabetic Neuropathies (Diabetic Neuropathy) 09/2020 - 09/2017
2	Transthyretin-Related Hereditary Amyloidosis 01/2019 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017 - 01/2017
2	Multiple Organ Failure (MODS) 11/2015 - 12/2012
2	Epilepsy (Aura) 11/2008 - 01/2005
1	Spasm (Spasms) 10/2023
1	Arthralgia (Joint Pain) 10/2023
1	Hyperuricemia 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Fatty Liver 06/2022
1	Hypercholesterolemia 04/2022
1	Hyperplasia 01/2022
1	Poisoning 01/2022
1	Inflammation (Inflammations) 01/2022
1	Heart Failure 01/2022
1	Acute Lung Injury 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Muscular Dystrophies (Muscular Dystrophy) 01/2022
1	Arteriovenous Fistula 01/2022
1	Injection Site Reaction 11/2020
1	Pain (Aches) 11/2020
1	Porphyrias (Porphyria) 11/2020
1	Acute Intermittent Porphyria (Porphyria, Acute) 11/2020
1	Orthostatic Intolerance 03/2020

Drug/Important Bio-Agent (IBA)

10	patisiranIBA 10/2023 - 09/2017
8	Prealbumin (Transthyretin)IBA 10/2023 - 01/2019
4	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2018 - 04/2015
3	Histone Deacetylase InhibitorsIBA 11/2008 - 01/2005
3	Valproic Acid (Depakote)FDA LinkGeneric 11/2008 - 01/2005
2	LDL CholesterolIBA 06/2022 - 04/2022
2	Triglycerides (Triacylglycerol)IBA 06/2022 - 04/2022
2	gamma-oryzanolIBA 06/2022 - 04/2022
2	CholesterolIBA 06/2022 - 04/2022
2	oxidized low density lipoproteinIBA 06/2022 - 04/2022
2	Bexarotene (LGD1069)FDA Link 01/2021 - 02/2016
2	CreatinineIBA 11/2020 - 01/2020
2	Insulin ReceptorIBA 01/2018 - 04/2015
2	PlatinumIBA 01/2018 - 09/2017
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017 - 01/2017
1	Hypochlorous Acid (Hypochlorite)IBA 10/2023
1	CarbonIBA 04/2023
1	Investigational DrugsIBA 04/2023
1	Adenine FDA LinkGeneric 01/2023
1	AZ3451IBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	Galectin 1 (LGALS1)IBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	C-Type Lectins (C-Type Lectin)IBA 01/2023
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2023
1	Interleukin-15 (Interleukin 15)IBA 01/2023
1	CytokinesIBA 01/2023
1	DiamondIBA 09/2022
1	Amino Acids FDA Link 06/2022
1	Tyrosine (L-Tyrosine)FDA Link 06/2022
1	LipidsIBA 04/2022
1	HDL CholesterolIBA 04/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Heme Oxygenase-1IBA 01/2022
1	PPAR gammaIBA 01/2022
1	Dystroglycans (Dystroglycan)IBA 01/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Neprilysin (Neutral Endopeptidase)IBA 01/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022
1	ParaquatIBA 01/2022
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2021
1	InotersenIBA 01/2021
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Hemin (Panhematin)FDA Link 11/2020
1	givosiranIBA 11/2020
1	Acute Hepatic PorphyriaIBA 11/2020
1	Transaminases (Aminotransferases)IBA 11/2020
1	PorphobilinogenIBA 11/2020
1	Thioredoxin-Disulfide ReductaseIBA 10/2020
1	Selenoproteins (Selenoprotein)IBA 10/2020
1	AntioxidantsIBA 10/2020

Therapy/Procedure

9	Therapeutics 04/2023 - 01/2005
6	RNAi Therapeutics 11/2020 - 09/2017
3	Drug Therapy (Chemotherapy) 09/2017 - 04/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2020
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024
1	Immunotherapy 01/2023
1	Renal Dialysis (Hemodialysis) 01/2022
1	Intravenous Administration 11/2020
1	Radiotherapy 08/2020